Thermal ablation for papillary thyroid microcarcinoma located in the isthmus: a study with 3 years of follow-up.
Future Oncol
; 18(4): 471-480, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35048734
ABSTRACT
Aims:
To analyze the outcomes of thermal ablation for isthmic papillary thyroid microcarcinoma (PTMC). Patients &methods:
Data for 21 isthmic-PTMC patients who underwent microwave ablation under ultrasound guidance were retrospectively collected. General information on patients and characteristics of tumors were collected. The technical effectiveness, tumor recurrence and volume changes and postoperative complications were recorded during the follow-up. Comparisons with 105 nonisthmic-PTMCs were done.Results:
The technical effectiveness was 100%. No recurrence or lymph node metastases were detected. Tumor volume decreased significantly with a volume reduction rate of 1.00 ± 0.01 (range 0.99 - 1.0) at the final evaluation and seven cases (31.8%) were completely resolved. No complication was encountered. No statistical differences were observed in terms of complications, recurrence or the volume reduction rate compared with the nonisthmic group (all p > 0.05).Conclusions:
Percutaneous microwave ablation is an effective treatment strategy for isthmic-PTMC.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Carcinoma, Papillary
/
Radiofrequency Ablation
Type of study:
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Future Oncol
Year:
2022
Document type:
Article
Affiliation country:
China